Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Lundbeck
Company Monitoring Page for Lundbeck
latest headlines for company on cafepharma
Lundbeck tops Q3 expectations following strong sales of mental health drugs
Pharmaforum
Tue, 11/3/20 - 10:47 am
Tags:
Lundbeck
,
earnings
Lundbeck gets cold feet, axes schizophrenia drug trial
Pharmaforum
Thu, 08/6/20 - 11:03 pm
Tags:
Lundbeck
,
schizophrenia
,
clinical trials
,
Lu AF11167
Lilly touts Emgality's ability to reduce migraine patients' overall pain in first look at 'holistic approach'
Fierce Pharma
Wed, 06/17/20 - 09:52 pm
Tags:
Eli Lilly
,
migraines
,
Amgen
,
Teva Pharmaceutical
,
Lundbeck
,
Emgality
Lundbeck plotting up to 160 R&D job cuts as it rebuilds pipeline
Fierce Biotech
Tue, 06/9/20 - 12:22 pm
Tags:
Lundbeck
,
R&D
,
layoffs
Ovid's lead drug shows promising efficacy signal in Fragile X syndrome study, but optimal dosing regimen is unclear for path forward
Endpoints
Fri, 05/8/20 - 10:34 am
Tags:
Ovid Therapeutics
,
Takeda
,
Lundbeck
,
Fragile X syndrome
,
clinical trials
Lundbeck adds a Parkinson's flop to its list of setbacks, writing off a $1.1 billion deal on mid-stage failure
Endpoints
Mon, 03/30/20 - 10:47 am
Tags:
Lundbeck
,
R&D
,
Parkinson's Disease
,
foliglurax
The fourth CGRP migraine drug is here. Time for Lundbeck to prove it's worth $2B
Endpoints
Sat, 02/22/20 - 11:29 pm
Tags:
Lundbeck
,
eptinezumab
,
migraines
,
CGRPs
,
Vyepti
Go or no go? Esperion's double whammy and a look to priority reviews
EP Vantage
Thu, 01/30/20 - 10:43 am
Tags:
FDA
,
Esperion Therapeutics
,
Acacia Pharma
,
Blueprint Medicines
,
Agile Therapeutics
,
Lundbeck
,
Sun Pharma
,
Biohaven
,
Durect Corporation
Lundbeck’s digital strategy and how they manage global and local content
Pharmaforum
Tue, 10/15/19 - 10:20 am
Tags:
Lundbeck
,
digital strategy
,
digital pharma
,
digital marketing
Biopharma M&A: deal-depressed third quarter leaves nowhere to hide
EP Vantage
Tue, 10/8/19 - 10:53 am
Tags:
M&A
,
Lundbeck
,
Alder Biopharmaceuticals
,
Gilead Sciences
,
Galapagos
,
Vertex Pharmaceuticals
,
Semma
,
Swedish Orphan Biovitrum
,
Dova Pharmaceuticals
,
Novartis
,
IFM
Alder's migraine drug attracted plenty of dealmakers. The company, not so much
Biopharma Dive
Wed, 09/25/19 - 09:17 am
Tags:
Alder Biopharmaceuticals
,
M&A
,
Lundbeck
Alder won’t solve Lundbeck’s headaches
EP Vantage
Mon, 09/16/19 - 05:12 pm
Tags:
Lundbeck
,
M&A
,
Alder Biopharmaceuticals
,
migraines
Lundbeck pens $2B Alder takeover to boost brain disease pipeline
Fierce Biotech
Mon, 09/16/19 - 09:23 am
Tags:
Lundbeck
,
Alder Biopharmaceuticals
,
M&A
Lundbeck strikes $250M Abide buyout, bagging Tourette's drug
Fierce Biotech
Mon, 05/6/19 - 10:50 am
Tags:
Lundbeck
,
Abide Therapeutics
,
M&A
,
Tourette's syndrome
Jazz Pharma, Lundbeck and Alexion Pay $122 Million to Settle Kickback Allegations
BioSpace
Thu, 04/4/19 - 11:02 pm
Tags:
Jazz Pharma
,
Lundbeck
,
Alexion
,
kickbacks
,
charity
Lundbeck fund backs a $50M launch round for SNIPR Biome, a new brand of CRISPR Cas biotech
Endpoints
Mon, 03/11/19 - 09:56 am
Tags:
Lundbeck
,
Lundbeck Foundation
,
startups
,
CRISPR
,
SNIPR Biome
Lundbeck joins with Elsevier to help manage R&D data
Pharmaforum
Thu, 02/28/19 - 09:47 am
Tags:
Lundbeck
,
R&D
,
Elsevier
,
Reaxis
Antipsychotic from Lundbeck, Otsuka flops again in PhIII trials — this time in bipolar patients
Endpoints
Thu, 02/14/19 - 05:45 pm
Tags:
Lundbeck
,
Otsuka
,
brexpiprazole
,
anti-psychotic
,
schizophrenia
,
bipolar disorder
FDA Approves First Generic Version of Lundbeck’s Sabril
RAPS.org
Wed, 01/16/19 - 11:54 pm
Tags:
FDA
,
Teva Pharmaceutical
,
Lundbeck
,
seizures
,
generics
,
Sabril
,
Vigabatrin
Lundbeck Partners with AI Driven Numerate to Tackle Central Nervous System Disorders
CP Wire
Mon, 01/7/19 - 10:14 am
Tags:
Lundbeck
,
Numerate
,
artificial intelligence
,
CNS
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.